JOLT HEALTH INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.005 CAD | -.--% |
|
-.--% | -.--% |
| 30/04 | Jolt Health Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 27/03 | Jolt Health Inc. announced that it has received CAD 0.5 million in funding | CI |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
| Sales 2022 | - | Sales 2023 | - | Capitalization | 386K 528K 32.26M |
|---|---|---|---|---|---|
| Net income 2022 | -3M -4.1M -250M | Net income 2023 | - 0 0 | EV / Sales 2022 | - |
| Net Debt 2022 | 104K 142K 8.65M | Net cash position 2023 | 2.06K 2.81K 172K | EV / Sales 2023 | - |
| P/E ratio 2022 |
-0.58
x | P/E ratio 2023 |
-0.43
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 98.66% |
More Fundamentals
* Assessed data
More news
More press releases
More news
1 month
0.01
0.01
Current year
0.010.01
1 year
0.010.03
3 years
0.011.50
5 years
0.011.50
10 years
0.011.50
| Managers | Title | Age | Since |
|---|---|---|---|
Gerald Tritt
CEO | Chief Executive Officer | - | 02/23/02 |
| Founder | - | 15/94/15 | |
Tatiana Kovaleva
DFI | Director of Finance/CFO | 67 | 27/18/27 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Founder | - | 15/94/15 | |
Douglas Taylor
BRD | Director/Board Member | - | 01/18/01 |
Gerald Tritt
CEO | Chief Executive Officer | - | 02/23/02 |
Jolt Health Inc. is a Canada-based life sciences company focused on healthcare, biotechnology and artificial intelligence. The Company holds licenses for therapeutic and pharmaceutical products throughout Europe, the United Kingdom, and North America. The Company's Wellness Product Portfolio is comprised of wellness products and the underlying intellectual property, concentrating on sexual health, with or without the benefit of CBD, acquired pursuant to various product licenses. In particular, the Company has rights to utilize a range of products and the related intellectual property pursuant to the product licenses, including CBD oral strips, Arouse RX gel with CBD and/or THC, CBD/THC biphasic mints/candies, Female Sexual Dysfunction supplement (FSD Supplement), ToConceive, and Male Enhancement Gel With CBD.
Sector
Pharmaceuticals
Calendar
23/05/2024
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 465K | |
| +26.08% | 662B | |
| +21.13% | 546B | |
| -4.77% | 359B | |
| +16.97% | 323B | |
| +5.69% | 289B | |
| +13.68% | 234B | |
| +4.61% | 198B | |
| -10.55% | 194B | |
| +8.08% | 167B |
- Stock Market
- Equities
- JOLT Stock